Stevanato Group S.p.A. (NYSE:STVN) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Stevanato Group S.p.A. (NYSE:STVN) have been assigned an average recommendation of “Moderate Buy” from the six research firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company.

Several research firms have commented on STVN. Morgan Stanley restated an “equal weight” rating and set a $23.00 price objective (down from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Wolfe Research began coverage on Stevanato Group in a report on Friday, December 13th. They issued an “outperform” rating and a $28.00 price target on the stock. Finally, Bank of America upped their price objective on Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday, December 13th.

Stevanato Group Stock Performance

STVN stock opened at €21.90 ($22.58) on Tuesday. The firm has a market cap of $6.47 billion, a price-to-earnings ratio of 46.60, a PEG ratio of 10.49 and a beta of 0.56. Stevanato Group has a twelve month low of €16.56 ($17.07) and a twelve month high of €34.73 ($35.80). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The business’s fifty day simple moving average is €21.29 and its two-hundred day simple moving average is €20.27.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of €0.13 ($0.13) by (€0.01) (($0.01)). The company had revenue of €277.90 million for the quarter, compared to the consensus estimate of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The company’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.16 EPS. Analysts predict that Stevanato Group will post 0.5 earnings per share for the current year.

Institutional Trading of Stevanato Group

A number of institutional investors have recently made changes to their positions in the business. Natixis Advisors LLC raised its stake in Stevanato Group by 27.3% in the second quarter. Natixis Advisors LLC now owns 42,674 shares of the company’s stock valued at $783,000 after buying an additional 9,146 shares during the last quarter. TD Asset Management Inc raised its position in shares of Stevanato Group by 324.2% in the 2nd quarter. TD Asset Management Inc now owns 108,853 shares of the company’s stock valued at $1,996,000 after purchasing an additional 83,191 shares during the last quarter. Thornburg Investment Management Inc. boosted its stake in Stevanato Group by 279.1% in the 2nd quarter. Thornburg Investment Management Inc. now owns 746,218 shares of the company’s stock worth $13,690,000 after purchasing an additional 549,378 shares in the last quarter. Oppenheimer Asset Management Inc. grew its position in Stevanato Group by 59.2% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 11,941 shares of the company’s stock worth $219,000 after purchasing an additional 4,441 shares during the last quarter. Finally, Blair William & Co. IL acquired a new position in Stevanato Group during the 2nd quarter valued at approximately $387,000.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.